Senior insider sale
Senior Vice President, R&D at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$764.8K
21.55K shares
What this filing means
ROTE WILLIAM E. plans to sell 21.55K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $764.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/22/2026ACC: 0001959173-26-003030
Officer· Senior Vice President, R&D
Since Nov 2018
21.55K
Shares to sell
$764.8K
Approx. market value
9.10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
4/13/2026
9.10KTotal acquired9.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Restricted Stock Vesting Compensation | 9.10K | — |
| Total | 9.10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
12.45K
Market value
$409.1K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.10K
Market value
$355.7K
4/22/2026
Total
Units
21.55K
Value
$764.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 12.45K | $409.1K | — | Completed |
| Planned — Approximate Date | ||||
4/22/2026 | 9.10K | $355.7K | NASDAQ | Planned |
| Total | 21.55K | $764.8K | ||